Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance

Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance

Pharmacological Research. Vol. 29, No. I. 1994 31 ANXIOLYTIC PROFILES OF ALPRAZOLAM AND ETHANOL IN THE ELEVATED PLUS-MAZE TEST AND THE EARLY ACQUISI...

745KB Sizes 0 Downloads 30 Views

Pharmacological Research. Vol. 29, No. I. 1994

31

ANXIOLYTIC PROFILES OF ALPRAZOLAM AND ETHANOL IN THE ELEVATED PLUS-MAZE TEST AND THE EARLY ACQUISITION OF SHUTTLEBOX AVOIDANCE M. PRUNELL*,

R. M. ESCORIHUELAt, A. FERNANDEZ-TERUELt, J. F. NfiREZt and A. TOBERAt

“Laboratorio de Fisiologia Animal, Facultad de Biologia, Universidad de la Laguna, Tenerife, Spain and I‘Unitat de Psicologia Mbdica, Dept. de Farmacologia i Psiquiatria, Facultat de Medicina, Universidad Autbnoma de Barcelona, 08193-Bellaterra, Barcelona, Spain Received in final form

27 July 1993

SUMMARY Rats pretreated either with the anxiolytic triazolobenzodiazepine alprazolam (0.75 and 1.75 mg kg-’ i.p.) or ethanol (1, 2, 3 and 4 g kg-’ p.o.) were tested in both the elevated plus-maze and the early acquisition of shuttlebox avoidance. Both substances induced overall anxiolytic effects in the plus-maze, with the 0.75 mg kg-’ being the most effective alprazolam dose and l-3 g kg-’ being the most effective ethanol doses. Both drugs were also anxiolytic in the shuttlebox, since 1.75 mg kg-’ alprazolam and 2-3 g kg-’ ethanol improved acquisition of the task. Correlational and factor analysis showed that behaviour in the open arms of the plus-maze and efficiency in shuttlebox avoidance acquisition are positively associated, thus providing further support to the contention that the early acquisition of shuttlebox avoidance is an animal model of anxiety. KEY WORDS: alprazolam.

plus-maze,

shuttlebox

acquisition,

correlations,

anxiety

models,

ethanol,

INTRODUCTION A considerable amount of behavioural and pharmacological evidence has provided support for the contention that the early acquisition of two-way active (shuttlebox) avoidance is a valid animal model of anxiety. In fact, it has been shown that: (1) the initial steps of that task appear to involve a bidirectional (i.e. passive vs active) avoidance conflict in which an early conditioned emotional response (i.e. ‘conditioned fear’, see [l-3]) is responsible for a tendency to freeze (i.e. passive avoidance of the opposite compartment), which runs against actively learning to avoid the shock (i.e. to adaptatively cope by crossing to the opposite compartment [l-3]; (2) Several antianxiety drugs (diazepam, chlordiazepoxide, flurazepam, medazepam, nitrazepam, alprazolam, adinazolam, amobarbital, pentobarbital, etc) 0 1994 The Italian Pharmacological

Society

3x

Pha~niac,olo,~icrrl

Rrseamh.

Vol. 29, No. I. 1994

improve the early acquisition (i.e. during the initial stages or trials) of shuttlebox avoidance in rats and mice [4-131; (3) Manipulations which reduce emotional reactivity or fearfulness in rats, such as postnatal handling [14, 151 or repeated (14-day) handling of adolescent rats [6, 161 improve shuttlebox avoidance acquisition [6, 17-211; (4) The less fearful female rats are better in shuttlebox avoidance acquisition than the relatively more fearful male rats [22]; (5) Maudsley Reactive rats (genetically selected for high fearfulnes or emotionality in the open field test) are poorer performers in shuttlebox acquisition than Maudsley Nonreactive rats (genetically selected for low emotional reactivity in the open field; for a review see [23]), and, congruently, Roman high-avoidance rats (selected for good shuttlebox acquisition) are less emotionally reactive than Roman low-avoidance rats (selected for poor shuttlebox acquisition; see [23]; (6) Psychological manipulations leading to increased fearfulness, as well as the administration of anxiogenic drugs (FG 7 142, Ro 15-45 13, partial inverse agonists of benzodiazepine receptors), impair the acquisition of shuttlebox avoidance [S, 20, 21, 241; (7) The rate of acquisition of shuttlebox avoidance is inversely correlated with the rate of ultrasonic vocalization in rats [25]. The anxiolytic effects of drugs in the early acquisition of shuttlebox avoidance appear after very few (between the first 10 to 40) trials in a single session, and are typically reflected by an increase in the number of avoidances or a reduction of escape/avoidance latency, or both [4-7, 261. On the other hand, the elevated plus-maze, consisting of measures of spontaneous behaviour on two open and two enclosed arms forming a ‘+’ sign, is another well validated and much more widely used test of anxiety in rats and mice (see for instance [27-301). The anxiolytic effects of drugs are usually indicated by an increase in the number of entries made, and/or time spent, by the animals in the open arms [27-301. Benzodiazepines and ethanol, though acting at different sites of the GABAbenzodiazepine receptor complex, share a number of behavioural effects, one of which is an anti-anxiety action in animal models [see 28, 29, 31-371. Nevertheless, no study has thus far reported a similar anxiolytic-like effect of ethanol in the early acquisition of shuttlebox avoidance (that is, in a single short40 trials or less-session). Thus, the first objective of the present study was to extend the validation of the early acquisition of shuttlebox avoidance (i.e. one single short session) as an animal model of anxiety by testing the effects of several ethanol doses and comparing them with those of a benzodiazepine (in this case, alprazolam). The second objective was to evaluate the possible (and expected) correlations between shuttlebox avoidance acquisition and behaviour in the elevated plus-maze test 127,291, in order to provide evidence on the validity of the former by using an independent criterion. MATERIAL

AND METHODS

Atlimds

Forty-four male Sprague-Dawley rats, weighing 230-310 g (obtained from Iffa Credo, France) were used in the study. They were housed 2-3 per cage under

Phar.mac~olo~ic~ul Rescwrc~h. l’ol. 29, No. I, 1994

39

regulated light/dark conditions (light, 08:OO to 20:00) with food and water freely available, and controlled temperature (22f2”C) and relative humidity (.50+10%). The experiment was carried out from 9:00 hrs to 14:00 hrs.

Behaviouaul tests Elellated plus-maze. Twenty minutes after drug administration, animals were tested for 5 min in the elevated plus-maze consisting in two open arms, 50x10 cm, and two enclosed arms, 50x10~40 cm, with an open square of 10x10 cm in the centre of the ‘+’ sign. The maze was elevated to a height of 50 cm [27]. Total arm entries (TE) and the number and duration of the entries into the open and enclosed arms were scored. From these parameters the percentage of open arm entries (% EOA=open arm entries/TExlOO) and of time spent in the open arms (%TOA=time open arms/[time open arms+time enclosed arms]xlOO) were calculated and used for analysis [27]. Two identical shuttlebox chambers (Letica Shuttlebox uvoidunce ucquisition. Inst.) were employed. The testing session included 10 min of habituation, immediately followed by a series of 20 trials of avoidance acquisition. Each trial consisted of 10 s of conditioned stimulus (CS, light and tone simultaneously), followed by a 0.6 mA footshock of 30 s as aversive unconditioned stimulus (US). The intertrial interval was 30 s. The number of avoidances (crossings in the presence of CS) during the first 10 trials (AVOIDlO) and during the whole sessions (AVOID20), as well as the respective mean escape latencies (LATlO and LAT20; mean time elapsing between the CS presentation and the response) were scored. The animals were introduced into the shuttlebox 30 min after drug administration and 5 min after testing in the elevated plus-maze.

Drug administration und experimental pinups In experiment 1, alprazolam (Upjohn Farmoquimica S.A.), at doses of 0.75 (n= 5) and 1.75 (n=5) mg kg-‘, was suspended in 1% carboxymethyl cellulose (cmc) and administered i.p. in a volume of 2 ml kg-‘. Control animals (n=5) received cmc at the same volume. In experiment 2, ethanol (Panreac), at doses of 1 (n=5), 2 (n=5), 3 (n=7) and 4 (n=5) g kg-‘, was given p.o. in a 20% v/v solution in tap water. Control animals (n=7) received tap water at the same volume. Both experiments were carried out within a 2-week period.

Stutisticctl unulysis One-way analysis of variance was applied to the data. Duncan’s Multiple Range tests were used for comparisons between groups. Correlational (Pearson’s coefficient) and factor analysis, including both plusmaze and shuttlebox testing measures, were applied to all the animals from the present two experiments (n=44) and to control animals (n=23). In the case of control animals, the number of rats was increased to 23 because an additional control group (n=l 1; treated and tested as in experiment 2 and during the same

40

Pharmacolo,~ical

period) from a separate experiment ‘n’ only for that analysis.

was included

Research,

with the purpose

Vol. 29, No. I, 1994

of increasing

RESULTS Alprazolam (experiment I, Table I) overall enhanced %EOA (F(2,12)=3.51, P= 0.06) and %TOA (F(2,12)=4.11, P~0.05) in the elevated plus-maze, the difference between 0.75 mg kg-’ alprazolam and vehicle groups reaching statistical significance for both parameters (P-cO.05, Duncan’s test), whereas a nonsignificant tendency was also observed at the 1.75 mg kg-’ dose (see Table I). The 1.75 mg kg-’ dose improved shuttlebox avoidance acquisition, as shown by a significant increase in AVOID10 (F(2,12)=3.64, P=O.O6; P~0.05 vs vehicle group, Duncan’s test) and showed a similar tendency in AVOID20 (F(2,12)=2.63, P= 0.11, but t=2.97, P~0.02 v,s vehicle group), as well as by significant reductions of LATlO (F(2,12)=3.23, P=O.O8; P~0.05 vs vehicle group, Duncan’s test) and LAT20 (F(2,12)=4.8, P~0.04; P~0.05 vs vehicle group, Duncan’s test). In experiment 2 (Table I), all ethanol doses increased %EOA (F(4,24)=7.5, PC 0.001) and %TOA (F(4,24)=17.4, P
ikk!anS~SEM

Exp. 1 Alprazolam (mg kg-‘) Vehicle 0.75

TE

%EOA

%TOA

AVOID10

AVOID20

LATI 0

LAT20

16.6 (1.8) 11.6 (2.9)

26.2 (5.3) 48.8* (4.7) 46.4 (9.0)

17.5 (4.9) .57.7* (10.9) 38.3 (12.3)

1.2 (0.4) 1.5 (0.5)

3.0 (1.0) 4.7 (1.9) 6.8 (0.8)

19.8 (4.8) 14.2 (2.6) 9.5* (0.5)

18.7 (2.7) 13.5 (3.2)

9.4 (1.1) 21.0* (2.3) 26.0* (3.8) 26.7* (4.0) 13.2 (2.5)

21.9 (2.3) 56.3* (3.9) 60.3* (1.1) 60.5* (3.4) 47.9* (19.3)

7.1 (1.3) 56.9* (6.0) 58.5* (1.5) 66.0* (3.2) 52.0* (16.7)

1.7 (0.6) 3.0 (0.8) 5.6* (1.7) 5.1* (1.4) 1.6 (0.4)

13.0 (0.8) 12.3 (1.0) Il.7 (0.9) 15.1 (1.7) 32.3* (3.5)

12.1 (1.0) Il.5 (0.7) 11.3 (0.7) 13.0 (1.4) 31.2* (4.1)

1.75

Exp 2 Ethanol (g kg-’ ) Vehicle I

2 3 4

Table I of plus-maze and shuttlebox acquisition

*P
test).

1.6 (0.7) 2.0 (0.7) 1.7

(0.6) 0.6 (0.2)

pharmacological

Research,

Vol. 29, No. 1, I994

41

AVOID20 (F(4,24)=2.9, P
Table II between sbuttlebox acquisition and performance in the elevated plus-maze test

Correlations 1 1. TE 2. %EOA 3. %TOA 4. AVOID10 5. AVOID20 6. LATlO 7. LAT20

-0.29 0.41t 0.65t 0.38t 0.6lj 0.20 0.44* 0.19 0.16 -0.05 0.20 -0.09

2

3

4

5

6

7

0.11 0.86-t -0.16 0.23 0.01 0.23 -0.22 -0.33* -0.26 -0.36*

0.43+ 0.31* 0.41+ 0.25 -0.15 -0.18 -0.12 -0.16

0.75t 0.70t -0.20 -0.44t -0.10 -0.34*

-0.15 -0.35* -0.28 -0.41*

-0.897 -0.94t

-

Upper values are control animals; n=23 because an additional control group, treated and tested as control rats from experiment 2 and during the same two-week period, has been included in order to increase the number of animals for performing correlations. Lower values are all the animals (n=44; vehicle- plus drug-treated groups) used in the present two experiments. +P
Table III Factor (principal-components) analysis between plus-maze measures from control animals and from the whole sample Control

Variables (loadings) TE %EOA %TOA AVOID10 AVOID20 LATlO LAT20 Percentage of explained variance

animals ._.~ 1

-

and shuttlebox (‘All animals’) All animals

I

0.15 -0.08 0.74 0.87 0.82 -0.30 -0.21

0.42 0.72 0.66 0.69 0.67 -0.74 -0.74

30%

45%

‘Control animals’ (n=23) and ‘all animals’ (n=44) as in Table II. Symbols and II. Loadings 2.30 are considered as significant.

as in Tables

I

DISCUSSION As in previous studies, which involved only shuttlebox avoidance testing ([4-71, and two more unpublished replications), alprazolam (a well known anxiolytic triazolobenzodiazepine) improved shuttlebox avoidance acquisition (by increasing avoidances and reducing latencies) and also showed the expected [30] anxiolytic effects in the plus-maze test. Since alprazolam (Experiment 1) was also included to test the reliability of the present (repeated testing) design, the results indicate that the present procedure (i.e. plus-maze testing plus shuttlebox avoidance testing) retains the sensitivity of both tests (as when they are used independently) for detecting the anxiolytic effects of drugs [4-7, 29, 301, and thus it is unlikely that the previous plus-maze administration could have produced artifactual influences on shuttlebox testing. On the other hand, the obvious advantage of the present procedure is that of testing the predicted possible correlations between the performance in both anxiety models (see below). The effects of ethanol during the process of acquisition of shuttlebox avoidance in random bred rats were studied by Chesher [38]. However, in that study, rats were tested in six consecutive IO-trial shuttlebox avoidance sessions (24-h interval between sessions [38]) after ethanol pretreatment (one injection of 1.5 or 2 g kg-’ i.p., in Wistar or Sprague-Dawley rats respectively, before each test). The results indicated that ethanol improved avoidance behavior only after the third training session [38]. In a different study Prune11 et al. [39] reported that acute ethanol (2 g kg-’ p.o.) shortened avoidance latencies in overtrained rats (their performance being 100% of avoidances when the treatment was administered). But, due to the procedures used, none of those studies provided evidence on the issue of whether ethanol could improve shuttlebox avoidance acquisition during its very early stages (as benzodiazepines do [4-7]), since it is during that phase when the conflict present in the task involves the maximum anxiety levels, and the

improving effects of environmental or pharmacological anxiolytic treatments are more evident [4,7, 10, II, 20, 211. Thus, the present study is, to our knowledge, the first dose-response study reporting positive effects of ethanol in the early acquisition (i.e. in a single short session) of shuttlebox avoidance, this being in agreement with the contention that moderate doses of ethanol display anxiolytic-like effects. It is, however, clear that the highest ethanol dose (4 g kg-‘) induces differential effects in both tests (i.e. it is anxiolytic in the plus-maze but has detrimental effects in shuttlebox acquisition), which is probably due to the different behavioural requirements involved in each situation, particularly to the fact that the perceptual and associative processes involved in the shuttlebox task (but not in the plus-maze) are probably disrupted by such a high ethanol dose. The moderate (but significant) correlations observed between plus-maze and shuttlebox acquisition measures (Table I), as well as their association in the principal-components analysis (Table Il), provide additional support for the hypothesis that the early acquisition of shuttlebox avoidance is an anxietymediated behaviour [l-7, 22-261. The most relevant associations between both tests indicate that, in control animals (n=23) AVOID10 and AVOID20 are positively correlated with %TOA, and, confirming this, the three measures have high loadings (0.74 to 0.87) of the same sign in the factor analysis. The consistency of those relationships is further confirmed by the fact that, in the whole sample of animals from both experiments (n=44), AVOID10 and %TOA are positively correlated and have positive loadings in the factor analysis (0.69 and 0.66, respectively), whereas, congruently, LATlO and LAT20 are inversely correlated with %EOA and also load inversely in the factor analysis (-0.74, -0.74 and 0.72. respectively). Also interesting is the fact that in control animals AVOID10 and AVOID20 correlated positively with TE, and the three measures loaded positively in the factor analysis (0.87, 0.82 and 0.75, respectively). However, those relationships became non-significant (see Table I) when including the drug-treated animals (n= 44), thus suggesting that there is little (if any) relationship between the effects of the drugs on general activity (i.e. TE) and their action on avoidance acquisition. This agrees with results from several previous studies which have indicated that shuttlebox avoidance acquisition cannot be completely accounted for by general activity levels 14, 5, 7, 20, 221. The within-test correlations show essentially the patterns that should be expected according to previous studies (see [4, 26, 27-29]), that is: (I) there are mostly positive correlations between the three plus-maze measures and positive loadings in the factor analysis (see [27-291); and (2) there are overall negative correlations between latency and avoidance parameters and inverse loadings of these measures in the factor analysis (see [4, 251). The only relevant exception to these patterns is the absence of correlation between %EOA and %TOA in control animals, which is probably due to the fact that %EOA scores in control animals were clearly higher than %TOA scores (Table I), whereas the values of both measures were overall much closer to each other in drug-treated rats (i.e. treatments led to similar within-group values in both %EOA and %TOA; see Table I). On the other hand, as indicated by pharmacological studies, both

44

Pharmacological Research, Vol. 29, No. 1, 1994

measures (i.e. %EOA and %TOA) are not always associated since experimental conditions can affect them differently [29]. Therefore, both the correlational and factor analyses (Tables I, II) show overall a positive association between behaviour in the open arms of the plus-maze and efficiency in shuttlebox acquisition. Thus, to summarize, two main new findings are reported in the present study which provide further evidence supporting the early acquisition of shuttlebox avoidance as an animal model of anxiety: (1) ethanol, like benzodiazepines, improves the early shuttlebox avoidance acquisition in rats and (2) positive relationships are shown between behaviour in the open arms of the plus-maze and the ability to solve the initial stages of the shuttlebox avoidance acquisition task.

ACKNOWLEDGEMENTS This work was supported by the DGICYT (PM88-007.5, PM92/0071). M.P. received a grant from the ‘Consejeria de Education de1 Gobierno de las Islas Canarias’, and R.M.E. was supported by the FISSs (92/0712).

REFERENCES 1. Gray JA. The neuropsychology of anxiety: an inquiry into the functions of the septohippocampal system. Oxford: Oxford University Press, 1982. 2. Gray JA. The psychology of fear and stress. Cambridge: Cambridge University Press, 1987. 3. Wilcock J, Fulker DW. Avoidance learning in rats: Genetic evidence for two distinct behavioral processes in the shuttle-box. J Comp Physiol Psycho1 1973; 82: 247-53. 4. Boix F, Femandez-Teruel A, TobeAa A. The anxiolytic action of benzodiazepines is not present in handling-habituated rats. Pharmacol Biochem Behav 1988; 31: 54146. 5. Fernandez-Teruel A, Escorihuela RM, Nufiez JF, Zapata A, Boix F, Salazar W, Tobefia A. The early acquisition of two-way (shuttle-box) avoidance as an anxiety-mediated behaviour: psychopharmacological validation. Brain Res Bull 1991; 26: 173-76. 6. Femandez-Teruel A, Escorihuela RM, Boix F, Tobefia A. Effects of different handlingstimulation procedures and benzodiazepines on two-way active avoidance acquisition in rats. Pharmacol Res 1991; 24: 273-82. 7. Escorihuela RM, Fernandez-Teruel A, Zapata A, Ntiiiez JF, Tobefia A. Flumazenil prevents the anti-anxiety effect of diazepam, alprazolam and adinazolam on the early acquisition of two-way active avoidance. Pharmacol Res 1993; in press. 8. Kamano DK, Martin LK, Powell BJ. Avoidance response acquisition and amobarbital dosage levels. Psychopharmacology 1966; 8: 3 19-23. 9. Robichaud RC, Sledge KM, Hefner MA, Goldberg ME. Propanolol and chlordiazepoxide on experimentally induced conflict and shuttle-box performance in rodents. Psyc,hopharmacology 1973; 32: 157-60. 10. Pereira ME, Dalmaz C, Rosat RM, Izquierdo I. Diazepam blocks the interfering effect-of post-training behavioral manipulations on retention of a shuttle avoidance task. Psychopharmacology 1988; 94: 402-A. I 1. Pereira ME, Rosat RM, Hui Hang CH, Godoy MGC, Izquierdo I. Inhibition by diazepam of the effect of additional training and of extinction on the retention of shuttle avoidance behavior in rats. Behav Neurosri 1989; 103: 202-5. 12. Sachs E, Weingarten M, Kleijn NW. Effects of chlordiazepoxide on the acquisition of

Pharmacological Research, Vol. 29, No. I, 1994

avoidance

45

learning

and its transfer to normal state and other drug conditions. 1966; 9: 17-30. M. Benzodiazepines and amphetamine on avoidance behaviour in mice. Arch

Psychopharmacology

13. Sansone

Int Pharmacodyn

Ther

1975; 218:

125-32.

14. Levine

15.

16.

17. 18. 19. 20.

21.

22. 23.

24. 25.

26.

27.

28.

S, Haltmeyer GC, Karas GG, Denenberg VH. Physiological and behavioral effects of infantile stimulation. Physiol Behav 1967; 2: 55-9. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239: 766-8. Biggio G, Corda MG, Concas A, Demontis G, Rossetti Z, Gessa GL. Rapid changes in GABA binding induced by stress in different areas of the rat brain. Brain Res 1981; 229: 363-9. Levine S, Chevalier JA, Korchin SJ. The effects of early shock and handling on later avoidance conditioning. J Personality 1956; 24: 475-93. Levine S. A further study of infantile handling and adult avoidance learning. J Personality 1956; 25: 70-80. Levine S, Wetzel A. Infantile experience, strain differences, and avoidance learning. J Comp Physiol Psycho1 1963; 56: 879-8 1. Escorihuela RM, Femandez-Teruel A, N6Aez JF, Zapata A, Tobefia A. Beneficial effects of infantile stimulation on coping (avoidance) behavior in rats are prevented by perinatal blockade of benzodiazepine receptors with Ro 15-1788. Neurosci Lett 1991; 126: 45-8. Escorihuela RM, Femandez-Teruel A, Ntiitez JF, Zapata A, Tobefia A. Infantile stimulation and the role of the benzodiazepine receptor system in adult acquisition of two-way active avoidance behavior. Psychopharmacology 1992; 106: 282-4. Gray JA, Lalljee B. Sex differences in emotional behaviour in the rat: correlation between open field defecation and active avoidance. Anim Behav 1974; 22: 856-61. Driscoll P, Blittig K. Behavioural emotional and neurochemical profiles of rats selected for extreme differences in active, two-way avoidance performance. In: Lieblich I, ed. Genetics ofthe brain. Amsterdam: Elsevier, 1982: 95-123. Weiss JM, Krichhaus EE, Conte R. Effects of fear conditioning on subsequent avoidance behavior and movement. J Comp Physiol Psycho1 1968; 65: 413-21. Cuomo V, Cagiano R, De Salvia MA, Mazzoccoli M, Persichella M, Renna G. Ultrasonic vocalization as an indicator of emotional state during active avoidance learning in rats. Life Sci 1992; 50: 1049-55. Boix F. Neurochemical and behavioral parameters of anxiety reduction in rats. Effects of benzodiazepine treatment and handling-habituation. Unpublished Doctoral Dissertation, Autonomous University of Barcelona, Barcelona, Spain, 1988. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci Meth 1985; 14: 149-67. Lister RG. The use of plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92:

29.

180-5.

Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986; 24: 525-9.

30.

File S, Pellow S. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol 1985; 86: 729-35. 3 I. Suzdak PI), Glowa JR, Crawley RD, Schwartz SM, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986; 234: 1243-7. 32. Glowa JR, Crawley J, Suzdak PD, Paul SM. Ethanol and the GABA receptor complex: Studies with the partial inverse receptor agonist Ro 15-4513. Pharmacol Biochem Behal 1989; 31: 767-72. 33.

Liljequist S, Engel JA. The effects of GABA and benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol. Pharmacol Biochem Behav 1984; 21: 521-5.

34. Lecci A, Borsini F, Volterra G, Meli A. Pharmacological validation of ;I novel animal model of anticipatory anxiety in mice. P.svc,llol,hur.n~nr,c~/~~,~~1990; 101: X-61. 35. Costall B, Kelly ME, Naylor RJ. The anxiolytic and anxlogcnic actions of ethanol in a mouse model. .I Phur-nz Phamad 1988; 40: 197-202. 36. Ticku MK. Alcohol and GABA-Benzodiazcpine receptor function. AUH MAY/ 1990; 22: 241-6. 37. Linnoila MM. Benzodiazepines and alcohol. .I P~ychiut Rcl.\1990; 24(Suppl. 2): I2 l-7. 3X. Chesher GB. Facilitation of avoidance acquisition in the rat by ethanol and its abolition by alpha methyl p-tyrosine. Ps~c,llr)~~~‘ha,-nlac,~~~~~~;~ (Red). 1974; 39: 87-95. 39. Prunell M, Boada J, Feria M, Benitez MA. Antagonism of the stimulant and depressant effects of ethanol in rats by naloxonc. Psvc’hol,hrrl.n7n~ol~),~~ 1987; 92: 2 1% IX.